Abbisko Therapeutics Announces that FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021) Read more
Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology Read more
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data Read more
Depixus Announces Strategic Collaboration With Daiichi Sankyo To Use MAGNA Technology To Accelerate RNA-Targeted Drug Discovery Read more
Japan’s Ministry of Health, Labour and Welfare accepts Arexvy (RSV vaccine) regulatory application to prevent RSV disease in adults aged 50-59 at increased risk Read more
Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies Read more
Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan Read more